رجوع
نطاق اليوم
KWD 5.51
KWD 5.51
نطاق 52 أسبوعًا
KWD 5.00
KWD 6.70
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 5.23
/
KWD 5.92
الإغلاق السابق
KWD 5.51
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 104.5 | 0.3 |
| P/B | 6.9 | 2.9 |
| ROE % | 6.7 | 3.7 |
| Net Margin % | 6.2 | 3.8 |
| Rev Growth 5Y % | 0.7 | 10.0 |
| D/E | 0.5 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2026 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
230 M | 0 |
النقاط الرئيسية
Revenue grew 0.74% annually over 5 years — modest growth
Earnings grew 22.61% over the past year
Generating 30.52M in free cash flow
P/E of 104.52 — premium valuation
Cash machine — converts 190.52% of earnings into free cash flow
Capital efficient — spends only 7.06% of revenue on capex
النمو
Revenue Growth (5Y)
0.74%
Revenue (1Y)-1.64%
Earnings (1Y)22.61%
FCF Growth (3Y)N/A
الجودة
Return on Equity
6.73%
ROIC5.67%
Net Margin6.22%
Op. Margin10.94%
الأمان
Debt / Equity
0.54
Current Ratio2.47
Interest Coverage4.78
التقييم
P/E Ratio
104.52
P/B Ratio6.90
EV/EBITDA62.37
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1.64% | Revenue Growth (3Y) | -3.14% |
| Earnings Growth (1Y) | 22.61% | Earnings Growth (3Y) | -25.96% |
| Revenue Growth (5Y) | 0.74% | Earnings Growth (5Y) | -10.68% |
| Profitability | |||
| Revenue (TTM) | 257.62M | Net Income (TTM) | 16.02M |
| ROE | 6.73% | ROA | 3.60% |
| Gross Margin | 29.65% | Operating Margin | 10.94% |
| Net Margin | 6.22% | Free Cash Flow (TTM) | 30.52M |
| ROIC | 5.67% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.54 | Current Ratio | 2.47 |
| Interest Coverage | 4.78 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 104.52 | P/B Ratio | 6.90 |
| P/S Ratio | 6.50 | PEG Ratio | -1.62 |
| EV/EBITDA | 62.37 | Dividend Yield | 0.00% |
| Market Cap | 1.67B | Enterprise Value | 1.76B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 257.62M | 261.91M | 274.63M | 287.34M | 250.10M |
| Net Income | 16.02M | 13.07M | 29.22M | 39.96M | 25.18M |
| EPS (Diluted) | 0.05 | 0.21 | 0.48 | 0.66 | 0.47 |
| Gross Profit | 76.39M | 64.85M | 79.49M | 87.71M | 68.99M |
| Operating Income | 28.18M | 25.44M | 40.01M | 48.18M | 32.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 445.06M | 466.58M | 397.50M | 368.53M | 331.90M |
| Total Liabilities | 202.53M | 233.25M | 172.32M | 162.77M | 159.36M |
| Shareholders' Equity | 242.53M | 233.33M | 225.18M | 205.76M | 172.55M |
| Total Debt | 130.53M | 141.37M | 87.15M | 85.30M | 109.58M |
| Cash & Equivalents | 47.16M | 33.53M | 22.67M | 47.18M | 37.56M |
| Current Assets | 223.50M | 247.98M | 211.39M | 188.02M | 156.28M |
| Current Liabilities | 90.35M | 96.43M | 60.25M | 45.67M | 35.67M |